Every 10-Q that AMN Healthcare Services (AMN) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow AMN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AMN filings page.
AMN Healthcare Services generated Q2 2026 revenue of $673.2 million, up 2% from $658.2 million a year earlier, and returned to profitability with $21.2 million of net income versus a prior-year loss. For the first half of 2026, revenue rose 52% to $2,051.6 million.
Growth was concentrated in nurse and allied solutions, where revenue nearly doubled to $1,549.3 million driven largely by large-scale labor disruption staffing, while physician and leadership and technology and workforce solutions revenues declined 6% and 15% year-to-date. Consolidated first-half gross margin was 28.0% versus 29.3% a year earlier, as pricing pressure and client losses weighed on technology offerings, partly offset by higher-margin labor disruption work. Operating cash flow more than doubled to $372.5 million, bolstering liquidity; the company ended June 30 with no borrowings on its $450 million revolver and $750 million of senior notes outstanding.
AMN Healthcare Services reported a sharp turnaround in Q1 2026, driven by large labor disruption projects. Revenue doubled to $1,378.4 million from $689.5 million, led by nurse and allied solutions, which surged to $1,127.3 million as AMN staffed multiple large-scale labor disruption events.
Net income swung to a profit of $62.2 million, or $1.60 per basic share, compared with a small loss a year earlier. Operating cash flow jumped to $562.5 million, reflecting sizable client deposits and higher segment operating income, and cash and cash equivalents rose to $560.7 million with the revolving credit facility fully repaid.
While nurse and allied solutions grew 173%, physician and leadership solutions revenue declined 6% and technology and workforce solutions fell 15%, pressured by lower locum tenens volume, weaker VMS and language pricing, and the sale of the Smart Square scheduling software. Consolidated gross margin narrowed to 26.8% from 28.7% as mix shifted and technology margins compressed, partly offset by higher-margin labor disruption work.
AMN Healthcare Services (AMN) filed its Q3 2025 report, showing revenue of $634.5 million, down from $687.5 million a year ago. Net income rose to $29.3 million from $7.0 million, with diluted EPS of $0.76 versus $0.18.
Year to date, revenue was $1,982.2 million versus $2,249.1 million, and the company reported a net loss of $88.0 million, primarily reflecting a non-cash goodwill impairment of $109.5 million and a $18.3 million long‑lived asset impairment recorded earlier in the year. Q3 included a $39.2 million gain on the sale of the Smart Square scheduling software, for which AMN received $65.3 million in cash and a $10.0 million 9.000% promissory note due January 1, 2027.
Operating cash flow reached $193.9 million for the nine months. Cash and cash equivalents were $52.6 million, and total stockholders’ equity was $644.4 million at September 30, 2025. Segment Q3 revenue: Nurse & Allied $361.5 million, Physician & Leadership $178.2 million, Technology & Workforce $94.8 million.
Subsequent events: On October 6, 2025, AMN issued $400.0 million of 6.500% senior notes due 2031 and amended its credit facility (maturity extended to October 6, 2030; revolving commitments set at $450.0 million; leverage covenant updated). On October 22, 2025, it redeemed the $500.0 million 2027 notes using note proceeds, revolver borrowings, and operating cash.